PROTECTED TAVR
2022
Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement
In 3,000 patients undergoing transcatheter aortic-valve replacement, the Sentinel cerebral embolic protection device did not reduce periprocedural stroke compared with no embolic protection.
Result
- Absolute difference
- 0.6 points
difference-0.695% CI -1.7 to 0.5 · P = 0.30
The absolute difference is derived from the event rates.
Also reported: Neutral. Disabling stroke numerically lower (0.5% vs 1.3%) but exploratory.
- Subtopic
- cerebral embolic protection
- Design
- Multicentre RCT
- Relevance
- Supporting: context rather than must-know.
- Source
- Kapadia SR, et al. N Engl J Med. 2022;387(14):1253-63.doi 10.1056/NEJMoa2204961
Discussion & critique
Observed overall stroke rate (~2.5%) far below the assumed 4%, leaving the trial underpowered; disabling-stroke signal only hypothesis-generating. Did not establish routine embolic protection.